22.10.2013 - Zivak Technologies, based in Istanbul, Turkey, relies on Tecan's Cavro® Omni Robot to automate liquid handling for its clinical diagnostic HPLC and LCMSMS systems. Mr Avni Çavdar, President of Zivak, explained: "Our Company was approached by several large government hospitals in Turkey that perform a great many organ transplants. Organ recipients are monitored frequently to ensure that they receive the appropriate dose of immunosuppressant drugs, and obtaining rapid, accurate results is crucial. We foresaw a future for the gold standard techniques of HPLC and LC-MS, and decided to develop and manufacture automated LC and LCMSMS analyzers for the clinical diagnostics market."
"To enable the sample preparation stages to be performed, we needed to integrate a precise and reliable liquid handling system - the Cavro Omni Robot. Combining the Cavro Omni Robot with our technologies enabled us to produce a series of fully automated HPLC and LC-MSMS based analyzers that can determine 25-OH metabolites of vitamin D2 and vitamin D3, immunosuppressants, amino acids and organic acids in minutes, rather than the hours that may be required for other assay types. The Cavro Omni Robot is very versatile, offering flexible sample handling for up to 180 samples per run, and can accommodate a range of different sample formats, allowing us to integrate a variety of modules. Reliability and accuracy are excellent, and we have demonstrated errors as low as 1 %."
To find out more about Tecan's Cavro Omni Robot, visit www.tecan.com/omnirobot
To find out more about Zivak's automated solutions, visit http://www.zivak.com
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).